Prosecution Insights
Last updated: October 25, 2026

Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita"

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita" operates within the Medical Devices & Mechanical Engineering technology area. The company currently has 1 pending office action across its portfolio. This workload is handled by 1 distinct examiner, showing a focused interaction with the patent office. The prosecution is localized within 1 distinct art unit, suggesting that the technical subject matter is categorized narrowly within the Medical Devices & Mechanical Engineering sector.

AZUBUOGU, CHIEMERIE CHIBUZOR is the busiest examiner for the company, currently overseeing 1 busiest examiner pending office action. For the applicant, the presence of 1 pending action under 1 distinct examiner in 1 distinct art unit simplifies the administrative tracking of the portfolio. The prosecution path is currently singular, as AZUBUOGU, CHIEMERIE CHIBUZOR is the only official reviewing the pending material. This alignment within a single art unit may lead to consistent examiner behavior if the portfolio expands within the same technology area.

Practitioners should note that the prosecution strategy is entirely dependent on the feedback from a single individual in a specific art unit. Because there is only 1 pending office action, the immediate success of the portfolio's legal efforts relies on resolving the issues raised by AZUBUOGU, CHIEMERIE CHIBUZOR. This concentrated structure minimizes the complexity often found in larger portfolios that span multiple art units or examiner groups. The company can focus its resources on the specific technical requirements of the Medical Devices & Mechanical Engineering unit where the application is lodged.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AZUBUOGU, CHIEMERIE CHIBUZOR 1 0.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18856209 PROSTHETIC COMPONENT OF A DENTAL IMPLANT AND AN ABUTMENT FOR ITS SCREW RETENTION AZUBUOGU, CHIEMERIE CHIBUZOR —

Top Art Units

Art UnitApps
3772 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18856209 PROSTHETIC COMPONENT OF A DENTAL IMPLANT AND AN ABUTMENT FOR ITS SCREW RETENTION AZUBUOGU, CHIEMERIE CHIBUZOR 3772 §102§103§112 Non-Final OA — Pending Oct 11, 2024

Managing Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita"'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita" have?

Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita" has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita" applications?

Chiemerie Chibuzor Azubuogu has the most, with 1 of Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita"'s pending office actions.

What technology area are Obschestvo S Ogranichennoi Otvetstvennostyu "Plasmovita"'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month